Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share financials
$14.39+0.56%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.2M | $31.3M | $31.1M | $31.1M | $29.1M | $29.7M | $28.1M | $29.6M | $27.5M | $29.3M | $29.1M | $28.7M |
| Gross profit | $25.4M | $24.9M | $25.1M | $25.2M | $23.5M | $23.6M | $22.6M | $23.7M | $21.9M | $23.5M | $29.1M | $28.7M |
| Gross margin | 81.2% | 79.6% | 80.7% | 80.9% | 80.8% | 79.5% | 80.5% | 79.8% | 79.8% | 80.3% | 100.0% | 100.0% |
| Operating income | $9.7M | $9.1M | $9.5M | $9.6M | -$6.6M | $7.6M | $7.0M | $7.8M | $6.4M | $8.7M | $9.4M | $8.5M |
| Net income | $2.4M | $1.8M | $13.7M | $890.0K | -$12.6M | $833.0K | $1.1M | $993.0K | -$11.1M | $3.0M | $3.9M | $2.9M |
| Net margin | 7.6% | 5.7% | 44.0% | 2.9% | −43.2% | 2.8% | 4.0% | 3.4% | −40.3% | 10.3% | 13.5% | 10.0% |
| Diluted EPS | $0.06 | $0.07 | $0.51 | $0.03 | $-0.50 | $0.03 | $0.04 | $0.04 | $-0.42 | $0.11 | $0.15 | $0.11 |
| EBITDA | $20.9M | $20.2M | $20.7M | $20.9M | $4.5M | $18.9M | $18.1M | $19.0M | $17.4M | $19.2M | $9.6M | $19.7M |
| Operating cash flow | $17.5M | $13.7M | $15.5M | $12.7M | $13.8M | $14.4M | $18.5M | $11.0M | $16.7M | $12.6M | $16.2M | $17.4M |
| Free cash flow | $13.3M | -$19.7M | -$19.6M | -$18.7M | -$141.0K | $9.7M | $5.2M | -$2.5M | -$14.0M | -$26.8M | $1.8M | -$38.4M |
| Diluted shares | 27.0M | 27.0M | 27.0M | 26.9M | 26.8M | 26.7M | 26.7M | 26.7M | 26.5M | 26.3M | 26.0M | 25.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.7M | $2.6M | $3.3M | $3.4M | $4.9M | $2.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $559.3M | $559.3M | $532.2M | $530.1M | $500.1M | $496.0M |
| Total assets | $1.00B | $1.01B | $990.8M | $987.3M | $966.3M | $985.1M |
| Total liabilities | $589.4M | $588.8M | $561.4M | $560.4M | $528.5M | $523.8M |
| Shareholders' equity | $414.2M | $421.3M | $429.4M | $426.8M | $437.8M | $461.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology